v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   14,476,000    
Beginning balance at Dec. 31, 2024 $ 133,584 $ 1 $ 239,715 $ (106,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 2,450   2,450  
Issuance of warrants in connection with March 2026 Amendment to the 2025 Loan Agreement 1,720   1,720  
Net loss (43,311)     (43,311)
Ending balance (in shares) at Mar. 31, 2025   14,476,000    
Ending balance at Mar. 31, 2025 94,443 $ 1 243,885 (149,443)
Beginning balance (in shares) at Dec. 31, 2024   14,476,000    
Beginning balance at Dec. 31, 2024 133,584 $ 1 239,715 (106,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (71,965)      
Ending balance (in shares) at Jun. 30, 2025   14,476,000    
Ending balance at Jun. 30, 2025 68,559 $ 1 246,655 (178,097)
Beginning balance (in shares) at Mar. 31, 2025   14,476,000    
Beginning balance at Mar. 31, 2025 94,443 $ 1 243,885 (149,443)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 2,770   2,770  
Net loss (28,654)     (28,654)
Ending balance (in shares) at Jun. 30, 2025   14,476,000    
Ending balance at Jun. 30, 2025 $ 68,559 $ 1 246,655 (178,097)
Beginning balance (in shares) at Dec. 31, 2025 14,577,609 14,578,000    
Beginning balance at Dec. 31, 2025 $ 7,993 $ 1 254,179 (246,187)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 2,653   2,653  
Issuance of shares upon exercise of stock options (in shares)   30,000    
Issuance of shares upon exercise of stock options 471   471  
Issuance of warrants in connection with March 2026 Amendment to the 2025 Loan Agreement 1,289   1,289  
Net loss (33,441)     (33,441)
Ending balance (in shares) at Mar. 31, 2026   14,608,000    
Ending balance at Mar. 31, 2026 $ (21,035) $ 1 258,592 (279,628)
Beginning balance (in shares) at Dec. 31, 2025 14,577,609 14,578,000    
Beginning balance at Dec. 31, 2025 $ 7,993 $ 1 254,179 (246,187)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (70,091)      
Ending balance (in shares) at Jun. 30, 2026 14,708,910 14,709,000    
Ending balance at Jun. 30, 2026 $ (52,977) $ 1 263,300 (316,278)
Beginning balance (in shares) at Mar. 31, 2026   14,608,000    
Beginning balance at Mar. 31, 2026 (21,035) $ 1 258,592 (279,628)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 3,104   3,104  
Issuance of shares upon exercise of stock options (in shares)   101,000    
Issuance of shares upon exercise of stock options 1,604   1,604  
Net loss $ (36,650)     (36,650)
Ending balance (in shares) at Jun. 30, 2026 14,708,910 14,709,000    
Ending balance at Jun. 30, 2026 $ (52,977) $ 1 $ 263,300 $ (316,278)